$-1.76
(Market cap
$21,562 Mln
Revenue (TTM)
$4,391 Mln
P/E Ratio
25.9
P/B Ratio
8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$719 Mln
-
ROE
0.3 %
-
ROCE
16.6 %
-
Industry P/E
44.07
-
EV/EBITDA
16
-
Debt to Equity
0.6
-
Book Value
$--
-
EPS
$5.5
-
Face value
--
-
Shares outstanding
151,300,000
10 Years Aggregate
CFO
$7,410.11 Mln
EBITDA
$427.43 Mln
Net Profit
$-315.44 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Illumina (ILMN)
| 9.2 | 12.8 | 22.6 | 78.4 | -11.0 | -17.0 | 0.7 |
|
BSE Sensex*
| -11.1 | -2.1 | -8.9 | -7.5 | 6.6 | 9.1 | 11.4 |
|
S&P 100
| 8.2 | 11.2 | 12.2 | 30.9 | 25.3 | 15.0 | 15.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Illumina (ILMN)
| -1.8 | -1.3 | -31.1 | -46.9 | 2.8 | 11.5 | 10.6 |
|
S&P 100
| 18.7 | 29.0 | 30.8 | -22.1 | 27.6 | 19.3 | 29.5 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Illumina (ILMN)
|
143.2 | 21,561.8 | 4,391.0 | 853.0 | 21.5 | 33.7 | 25.9 | 8.0 |
| 84.9 | 143,804.1 | 45,134.0 | 6,276.0 | 15.4 | 12.2 | 23.1 | 2.8 | |
| 144.5 | 39,443.6 | 21,365.0 | 1,138.0 | 9.9 | 4.6 | 25 | 1.7 | |
| 53.6 | 79,326.8 | 20,615.0 | 3,553.0 | 10.0 | 14.5 | 22.3 | 3.1 | |
| 164.5 | 117,858.0 | 24,778.0 | 3,689.0 | 18.7 | 7.1 | 32.3 | 2.3 | |
| 81.3 | 44,434.5 | 6,303.5 | 1,092.8 | 12.7 | 10.6 | 41.7 | 4.5 | |
| 532.9 | 41,965.8 | 4,446.1 | 1,095.2 | 23.5 | 70.3 | 39.2 | 28.4 | |
| 428.1 | 148,769.7 | 10,582.1 | 2,979.1 | 22.4 | 17.2 | 51 | 9.1 | |
| 305.5 | 108,223.7 | 25,270.0 | 3,337.0 | 14.8 | 15.1 | 32.7 | 4.8 | |
| 448.2 | 168,195.9 | 45,197.0 | 6,859.0 | 19.2 | 13.3 | 24.9 | 3.3 |
Shareholding Pattern
View DetailsAbout Illumina (ILMN)
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and... consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California. Address: 5200 Illumina Way, San Diego, CA, United States, 92122 Read more
-
CEO & Director
Mr. Jacob Thaysen Ph.D.
-
CEO & Director
Mr. Jacob Thaysen Ph.D.
-
Headquarters
San Diego, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Illumina (ILMN)
What is the current share price of Illumina Inc (ILMN) Today?
The share price of Illumina Inc (ILMN) is $143.24 (NASDAQ) as of 14-May-2026 16:13 EDT. Illumina Inc (ILMN) has given a return of -10.96% in the last 3 years.
What is the current PB & PE ratio of Illumina Inc (ILMN)?
The P/E ratio of Illumina Inc (ILMN) is 25.91 times as on 12-May-2026, a 41 discount to its peers’ median range of 44.07 times.
The P/B ratio of Illumina Inc (ILMN) is 8.02 times as on 12-May-2026, a 178 premium to its peers’ median range of 2.89 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
23.76
|
7.42
|
|
2024
|
-17.48
|
9.01
|
|
2023
|
-19.07
|
3.85
|
|
2022
|
-7.25
|
4.84
|
|
2021
|
78.38
|
5.56
|
What is the 52 Week High and Low of Illumina Inc (ILMN)?
The 52-week high and low of Illumina Inc (ILMN) are Rs 155.47 and Rs 77.55 as of 15-May-2026.
What is the market cap of Illumina Inc (ILMN)?
Illumina Inc (ILMN) has a market capitalisation of $ 21,562 Mln as on 12-May-2026. As per SEBI classification, it is a Large Cap company.
Should I invest in Illumina Inc (ILMN)?
Before investing in Illumina Inc (ILMN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.